| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF630-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB6301-SP | |||
| Carrier Free | MAB6301-500 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB630-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-14580-500ul | |||
![Western Blot: TRAILR3/TNFRSF10C Antibody [NBP1-76881] - Analysis of 20 ug of whole cell lysate from HeLa (Lane 1) and 293 (Lane 2) cells with anti-TRAIL-R3 at 1 ug/ml dilution. Image submitted by a verified customer review.](http://images.novusbio.com/fullsize2/TRAILR3-TNFRSF10C-Antibody-Western-Blot-NBP1-76881-img0002.jpg "Western Blot: TRAILR3/TNFRSF10C Antibody [NBP1-76881] - Analysis of 20 ug of whole cell lysate from HeLa (Lane 1) and 293 (Lane 2) cells with anti-TRAIL-R3 at 1 ug/ml dilution. Image submitted by a verified customer review.")
![Immunocytochemistry/Immunofluorescence: TRAILR3/TNFRSF10C Antibody [NBP1-76881] - HeLa cells with DcR1 antibody at 10 ug/mL.](http://images.novusbio.com/fullsize2/TRAILR3-TNFRSF10C-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-76881-img0006.jpg)
![Western Blot: TRAILR3/TNFRSF10C Antibody [NBP1-76881] - HeLa whole cell lysate with TRAIL-R3 antibody (ED) at 1:500 dilution.](http://images.novusbio.com/fullsize2/TRAILR3-TNFRSF10C-Antibody-Western-Blot-NBP1-76881-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: TRAILR3/TNFRSF10C Antibody [NBP1-76881] - Immunofluorescence of DcR1 in Hela cells with DcR1 antibody at 20 ug/mL.](http://images.novusbio.com/fullsize2/TRAILR3-TNFRSF10C-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-76881-img0005.jpg)
![Western Blot: TRAIL R3/TNFRSF10C Antibody [NB100-56445] - Analysis of TRAIL R3/TNFRSF10C 15 ug of mouse spleen cell lysate using this antibody.](http://images.novusbio.com/fullsize2/TRAIL-R3-TNFRSF10C-Antibody-Western-Blot-NB100-56445-img0003.jpg "Western Blot: TRAIL R3/TNFRSF10C Antibody [NB100-56445] - Analysis of TRAIL R3/TNFRSF10C 15 ug of mouse spleen cell lysate using this antibody.")
![Immunohistochemistry-Paraffin: TRAILR3/TNFRSF10C Antibody (TR3.06) [NBP2-80071] - Negative control.](http://images.novusbio.com/fullsize2/TRAILR3-TNFRSF10C-Antibody-(TR3.06)-Immunohistochemistry-Paraffin-NBP2-80071-img0002.jpg "Immunohistochemistry-Paraffin: TRAILR3/TNFRSF10C Antibody (TR3.06) [NBP2-80071] - Negative control.")
![Immunohistochemistry-Paraffin: TRAILR3/TNFRSF10C Antibody (TR3.06) [NBP2-80071] - Immunohistochemistry detection of endogenous TRAIL-R3 in paraffin-embedded human carcinoma tissues (colon, tonsil) using mAb to TRAIL-R3 (TR3.06).](http://images.novusbio.com/fullsize2/TRAILR3-TNFRSF10C-Antibody-(TR3.06)-Immunohistochemistry-Paraffin-NBP2-80071-img0001.jpg)
![Flow Cytometry: TRAILR3/TNFRSF10C Antibody (B-D44) [NBP3-14580] - A typical staining pattern with the B-D44 monoclonal antibody of granulocytes.](http://images.novusbio.com/fullsize2/TRAILR3-TNFRSF10C-Antibody-(B-D44)-Flow-Cytometry-NBP3-14580-img0001.jpg "Flow Cytometry: TRAILR3/TNFRSF10C Antibody (B-D44) [NBP3-14580] - A typical staining pattern with the B-D44 monoclonal antibody of granulocytes.")
![Flow Cytometry: TRAILR3/TNFRSF10C Antibody (003) [NBP2-89484] - Analysis of Human TNFRSF10C(CD263) expression on human whole blood granulocytes. Cells were stained with purified anti-Human TNFRSF10C(CD263), then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable granulocytes.](http://images.novusbio.com/fullsize2/TRAILR3-TNFRSF10C-Antibody-(003)-Flow-Cytometry-NBP2-89484-img0001.jpg "Flow Cytometry: TRAILR3/TNFRSF10C Antibody (003) [NBP2-89484] - Analysis of Human TNFRSF10C(CD263) expression on human whole blood granulocytes. Cells were stained with purified anti-Human TNFRSF10C(CD263), then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable granulocytes.")